Funding Archives

Digital Health Investment Trends in H1 2026: 5 New Rules of Healthcare Innovation Venture Capital

H1 2026 shows that digital health investors haven’t stepped back—they’re changing the rules. Digital health venture capital is operating under a new…

H1 2026 Healthcare Trends: Health Systems Are Buying Infrastructure, Not Apps

Health systems have stopped shopping for point solutions. H1 2026 data show the winners are the platforms that integrate seamlessly into clinical…

The Return of the Strategic Buyer: M&A Captured 98% of Digital Health Exits in H1 2026

Strategic acquirers have taken control of digital health liquidity: M&A captured 97.6% of exit volume in H1 2026, the highest share on…

H1 2026 Digital Health Trends: Why Partnerships Matter More Than Funding

Partnership formation has decoupled from funding as digital health's leading indicator. The pilot economy is ending — the market's most reliable signal…

Global funding held broadly steady at $22.6B — H1 2026 data shows capital concentrating in fewer, larger, more scrutinised bets.

As the first in a series covering the key digital health stories from H1 2026, this article concentrates on equity funding trends.…

Digital Health Exits in 2026: M&A Dominance, Longer Hold Periods, and Strategic Consolidation

Digital health liquidity remains steady, but the market has changed. For investors, corporates, and ventures, the winning strategy is less about waiting…

HealthTech Alpha data shows Europe’s startup problem is not formation. It is late-stage capital density and ownership retention

The €5 billion question: is Europe finally building strategic capital — or still thinking too small?

The European Commission’s new Scaleup Europe Fund is being dismissed as too small. The criticism is understandable. But HealthTech Alpha data suggests…

The $2.1bn wager on machine-made medicine: why Isomorphic Labs may redraw the economics of drug discovery

Isomorphic Labs’ $2.1bn Series B is not simply another oversized AI funding round. It is a signal that investors now believe artificial…

The Investable Core: Why Investors Are Backing Health Management Solutions in 2026

Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance

Roche acquires PathAI: pharma partners face a vendor-risk problem

Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance

AI in U.S. Healthcare Operations: Why Health Management Solutions Became the New Infrastructure Layer

Administrative overload, workforce shortages, and operating cost pressure have pushed U.S. healthcare beyond pilots: the United States now accounts for 41% of…

The Administration Problem: How $5.6B Rewired Health Management Solutions in 2025

Capital didn't just flow into Health Management Solutions in 2025 — 83% of it went to a single thesis: that AI must…

Articles in Funding

Articles

Overview

Category

Stage

Total Funding

GGA Score